Biodesix partners with chicago public schools for covid-19 testing to safely reopen schools

Boulder, colo.--(business wire)--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the company has partnered with chicago public schools (cps) to provide antigen and droplet digital pcr (ddpcr)™ testing for chicago public school teachers and staff. the cps testing program, which launched in january, is a surveillance testing protocol and uses rapid antigen tests to monitor the prevalence of covid-19 among asympto
BDSX Ratings Summary
BDSX Quant Ranking